Search Results - "Haluzik, M"

Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum by Šenolt, L, Housa, D, Vernerová, Z, Jirásek, T, Svobodová, R, Veigl, D, Anderlová, K, Müller-Ladner, U, Pavelka, K, Haluzík, M

“…Background: Resistin is a newly identified adipocytokine which has demonstrated links between obesity and insulin resistance in rodents. In humans,…”
Get full text

European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity by Pasquali, R, Casanueva, F, Haluzik, M, van Hulsteijn, L, Ledoux, S, Monteiro, M P, Salvador, J, Santini, F, Toplak, H, Dekkers, O M

“…Obesity is an emerging condition, with a prevalence of ~20%. Although the simple measurement of BMI is likely a simplistic approach to obesity, BMI is easily…”
Get full text

Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis by van Hulsteijn, L T, Pasquali, R, Casanueva, F, Haluzik, M, Ledoux, S, Monteiro, M P, Salvador, J, Santini, F, Toplak, H, Dekkers, O M

“…Objective The increasing prevalence of obesity is expected to promote the demand for endocrine testing. To facilitate evidence guided testing, we aimed to…”
Get full text

Continuing the success of Journal of Endocrinology and Journal of Molecular Endocrinology by Andrikopoulos, S, Farquharson, C, Haluzik, M

Get full text

Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity by Mraz, M., Bartlova, M., Lacinova, Z., Michalsky, D., Kasalicky, M., Haluzikova, D., Matoulek, M., Dostalova, I., Humenanska, V., Haluzik, M.

“…Summary Objective  Fibroblast growth factor‐21 (FGF21) is a novel endocrine and paracrine regulator of metabolic homeostasis. The aim of our study was to…”
Get full text

Changes in Energy Metabolism in Pheochromocytoma by Petrák, O, Haluzíková, D, Kaválková, P, Štrauch, B, Rosa, J, Holaj, R, Brabcová Vránková, A, Michalský, D, Haluzík, M, Zelinka, T, Widimský, J

“…Context: Catecholamine overproduction in pheochromocytoma affects basal metabolism, resulting in weight loss despite normal food intake. Objective: The…”
Get full text

Improvement of Insulin Sensitivity after Peroxisome Proliferator-Activated Receptor-α Agonist Treatment Is Accompanied by Paradoxical Increase of Circulating Resistin Levels by Haluzik, M. M, Lacinova, Z, Dolinkova, M, Haluzikova, D, Housa, D, Horinek, A, Vernerova, Z, Kumstyrova, T, Haluzik, M

“…We studied the effect of peroxisome proliferator-activated receptor-α (PPAR-α) activation on serum concentrations and tissue expression of resistin,…”
Get full text

Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus by Kleiblova, P., Dostalova, I., Bartlova, M., Lacinova, Z., Ticha, I., Krejci, V., Springer, D., Kleibl, Z., Haluzik, M.

“…The purpose of this study was to assess the expression profile of genes with potential role in the development of insulin resistance (adipokines,…”
Get full text

Relation of prediabetes and type 2 diabetes mellitus to thyroid cancer by Grimmichova, T, Haluzik, M, Vondra, K, Matucha, P, Hill, M

“…Objective Patients with type 2 diabetes (T2DM) generally experience a higher incidence of cancer. However, the association between T2DM and thyroid cancer is…”
Get full text

The Effect of Very-Low-Calorie Diet on mRNA Expression of Inflammation-Related Genes in Subcutaneous Adipose Tissue and Peripheral Monocytes of Obese Patients with Type 2 Diabetes Mellitus by Mraz, M, Lacinova, Z, Drapalova, J, Haluzikova, D, Horinek, A, Matoulek, M, Trachta, P, Kavalkova, P, Svacina, S, Haluzik, M

“…Subcutaneous adipose tissue and peripheral monocytes of obese type 2 diabetic patients exert a strong chemoattracting expression profile that is improved after…”
Get full text

Circadian leptin concentration changes in critically ill heart failure patients by Cundrle, Jr, I, Suk, P, Sramek, V, Lacinova, Z, Haluzik, M

“…Physiologically, leptin concentration is controlled by circadian rhythm. However, in critically ill patients, circadian rhythm is disrupted. Thus we…”
Get full text

Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic properties in obesity/type 2 diabetes mellitus by Dostálová, I, Haluzíková, D, Haluzík, M

“…Fibroblast growth factor 21 (FGF21) is a novel metabolic regulator produced primarily by the liver that exerts potent antidiabetic and lipid-lowering effects…”
Get full text

Metformin attenuates myocardium dicarbonyl stress induced by chronic hypertriglyceridemia by Malinska, H, Škop, V, Trnovska, J, Markova, I, Svoboda, P, Kazdova, L, Haluzik, M

“…Reactive dicarbonyls stimulate production of advanced glycation endproducts, increase oxidative stress and inflammation and contribute to the development of…”
Get full text

Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: The influence of very-low-calorie diet by Touskova, V., Trachta, P., Kavalkova, P., Drapalova, J., Haluzikova, D., Mraz, M., Lacinova, Z., Marek, J., Haluzik, M.

“…► We studied mRNA expression of IGF-1 axis components in monocytes and subcutaneous adipose tissue. ► Type 2 diabetic women had increased IGF-1R mRNA…”
Get full text

Increasing skeletal muscle fatty acid transport protein 1 (FATP1) targets fatty acids to oxidation and does not predispose mice to diet-induced insulin resistance by Holloway, G. P., Chou, C. J., Lally, J., Stellingwerff, T., Maher, A. C., Gavrilova, O., Haluzik, M., Alkhateeb, H., Reitman, M. L., Bonen, A.

“…Aims/hypothesis We examined in skeletal muscle (1) whether fatty acid transport protein (FATP) 1 channels long-chain fatty acid (LCFA) to specific metabolic…”
Get full text

Specific metabolic characteristics of women with former gestational diabetes: the importance of adipose tissue by Vejrazkova, D, Vankova, M, Lukasova, P, Vcelak, J, Cirmanova, V, Haluzik, M, Bendlova, B

“…Women with a positive history of gestational diabetes mellitus (GDM) face a higher risk of developing type 2 diabetes mellitus (T2DM) and metabolic syndrome…”
Get full text

No change in serum incretins levels but rise of leptin levels after smoking cessation: a pilot study by Pankova, A, Kralikova, E, Kavalkova, P, Stepankova, L, Zvolska, K, Haluzik, M

“…The mechanisms behind the changes of body weight after smoking cessation are only partially understood. To this end, we explored the possible effects of…”
Get full text

Effects of body weight reduction on plasma fibroblast growth factor 21 in obese patients with type 1 diabetes mellitus by Musil, F, Blaha, V, Ticha, A, Hyspler, R, Haluzik, M, Lesna, J, Smahelova, A, Sobotka, L

Get full text

Liver, but not adipose tissue PEDF gene expression is associated with insulin resistance by Moreno-Navarrete, J M, Touskova, V, Sabater, M, Mraz, M, Drapalova, J, Ortega, F, Serrano, M, Catalán, V, Gómez-Ambrosi, J, Ortiz, M R, Pardo, G, Pueyo, N, Ricart, W, Lacinova, Z, Haluzik, M, Frühbeck, G, Fernández-Real, J M

“…Objective: Recent studies linked circulating pigment epithelium-derived factor ( PEDF ) to obesity-associated insulin resistance, but the main source of…”
Get full text

Effects of body weight reduction on plasma leptin and adiponectin/leptin ratio in obese patients with type 1 diabetes mellitus by Musil, F, Blaha, V, Ticha, A, Hyspler, R, Haluzik, M, Lesna, J, Smahelova, A, Sobotka, L

“…The aim of this study was to explore the changes in the adipokines leptin and adiponectin in obese patients with type 1 diabetes mellitus (T1DM) who underwent…”
Get full text